# Champion Homes, Inc.: financial statements, quarterly

SKY · NYSE · CIK 90896 · [Materials](/sectors/materials.md) · fiscal year ends Mar 29

Pages: [Overview](/companies/sky.md) · [Financials](/companies/sky/financials.md) · [Filings](/companies/sky/filings.md) · [Insiders](/companies/sky/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sky/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [464](/filings/0000950170-24-118247.md) | [559](/filings/0000950170-25-014483.md) | [536 d](/filings/0001193125-26-239333.md) | [628](/filings/0000950170-25-104056.md) | [617](/filings/0001193125-25-266982.md) | [645](/filings/0001193125-26-037613.md) | [594 d](/filings/0001193125-26-239333.md) | [701](/filings/0001193125-26-335147.md) | [684](/filings/0001193125-25-266982.md) | [657](/filings/0001193125-26-037613.md) | [621 d](/filings/0001193125-26-239333.md) | [710](/filings/0001193125-26-335147.md) |
| Cost of revenue | $m | [348](/filings/0000950170-24-118247.md) | [418](/filings/0000950170-25-014483.md) | [438 d](/filings/0001193125-26-239333.md) | [464](/filings/0000950170-25-104056.md) | [451](/filings/0001193125-25-266982.md) | [464](/filings/0001193125-26-037613.md) | [441 d](/filings/0001193125-26-239333.md) | [511](/filings/0001193125-26-335147.md) | [496](/filings/0001193125-25-266982.md) | [484](/filings/0001193125-26-037613.md) | [467 d](/filings/0001193125-26-239333.md) | [531](/filings/0001193125-26-335147.md) |
| Gross profit | $m | [116](/filings/0000950170-24-118247.md) | [141](/filings/0000950170-25-014483.md) | [98.4 d](/filings/0001193125-26-239333.md) | [164](/filings/0000950170-25-104056.md) | [166](/filings/0001193125-25-266982.md) | [181](/filings/0001193125-26-037613.md) | [152 d](/filings/0001193125-26-239333.md) | [190](/filings/0001193125-26-335147.md) | [188](/filings/0001193125-25-266982.md) | [172](/filings/0001193125-26-037613.md) | [154 d](/filings/0001193125-26-239333.md) | [179](/filings/0001193125-26-335147.md) |
| Selling, general and administrative | $m | [64.5](/filings/0000950170-24-118247.md) | [85.1](/filings/0000950170-25-014483.md) | [90.6 d](/filings/0001193125-26-239333.md) | [109](/filings/0000950170-25-104056.md) | [99.7](/filings/0001193125-25-266982.md) | [108](/filings/0001193125-26-037613.md) | [110 d](/filings/0001193125-26-239333.md) | [111](/filings/0001193125-26-335147.md) | [113](/filings/0001193125-25-266982.md) | [110](/filings/0001193125-26-037613.md) | [118 d](/filings/0001193125-26-239333.md) | [119](/filings/0001193125-26-335147.md) |
| Operating income | $m | [52.0](/filings/0000950170-24-118247.md) | [56.2](/filings/0000950170-25-014483.md) | [7.8 d](/filings/0001193125-26-239333.md) | [55.4](/filings/0000950170-25-104056.md) | [66.7](/filings/0001193125-25-266982.md) | [72.8](/filings/0001193125-26-037613.md) | [42.2 d](/filings/0001193125-26-239333.md) | [78.5](/filings/0001193125-26-335147.md) | [74.8](/filings/0001193125-25-266982.md) | [62.5](/filings/0001193125-26-037613.md) | [36.0 d](/filings/0001193125-26-239333.md) | [60.3](/filings/0001193125-26-335147.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [14.8](/filings/0000950170-24-118247.md) | [12.8](/filings/0000950170-25-014483.md) | [2.3 d](/filings/0001193125-26-239333.md) | [13.7](/filings/0000950170-25-104056.md) | [15.4](/filings/0001193125-25-266982.md) | [16.7](/filings/0001193125-26-037613.md) | [7.9 d](/filings/0001193125-26-239333.md) | [17.7](/filings/0001193125-26-335147.md) | [18.6](/filings/0001193125-25-266982.md) | [12.4](/filings/0001193125-26-037613.md) | [8.1 d](/filings/0001193125-26-239333.md) | [17.0](/filings/0001193125-26-335147.md) |
| Net income | $m | [45.7](/filings/0000950170-24-118247.md) | [47.0](/filings/0000950170-25-014483.md) | [2.8 d](/filings/0001193125-26-239333.md) | [45.8](/filings/0000950170-25-104056.md) | [54.7](/filings/0001193125-25-266982.md) | [61.5](/filings/0001193125-26-037613.md) | [36.3 d](/filings/0001193125-26-239333.md) | [64.7](/filings/0001193125-26-335147.md) | [58.2](/filings/0001193125-25-266982.md) | [54.3](/filings/0001193125-26-037613.md) | [29.7 d](/filings/0001193125-26-239333.md) | [49.2](/filings/0001193125-26-335147.md) |
| Diluted EPS | $ per share | [0.79](/filings/0000950170-24-118247.md) | [0.81](/filings/0000950170-25-014483.md) | not reported | [0.79](/filings/0000950170-25-104056.md) | [0.94](/filings/0001193125-25-266982.md) | [1.06](/filings/0001193125-26-037613.md) | not reported | [1.13](/filings/0001193125-26-335147.md) | [1.03](/filings/0001193125-25-266982.md) | [0.97](/filings/0001193125-26-037613.md) | not reported | [0.89](/filings/0001193125-26-335147.md) |
| Basic EPS | $ per share | [0.80](/filings/0000950170-24-118247.md) | [0.81](/filings/0000950170-25-014483.md) | not reported | [0.79](/filings/0000950170-25-104056.md) | [0.95](/filings/0001193125-25-266982.md) | [1.07](/filings/0001193125-26-037613.md) | not reported | [1.13](/filings/0001193125-26-335147.md) | [1.03](/filings/0001193125-25-266982.md) | [0.97](/filings/0001193125-26-037613.md) | not reported | [0.90](/filings/0001193125-26-335147.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [701](/filings/0000950170-23-057501.md) | [498](/filings/0000950170-24-011727.md) | [495](/filings/0000950170-25-077746.md) | [549](/filings/0000950170-24-092813.md) | [570](/filings/0000950170-24-118247.md) | [582](/filings/0000950170-25-014483.md) | [610](/filings/0001193125-26-239333.md) | [605](/filings/0000950170-25-104056.md) | [619](/filings/0001193125-25-266982.md) | [660](/filings/0001193125-26-037613.md) | [638](/filings/0001193125-26-335147.md) | [785](/filings/0001193125-26-335147.md) |
| Current assets | $m | [978](/filings/0000950170-23-057501.md) | [870](/filings/0000950170-24-011727.md) | [918](/filings/0000950170-25-077746.md) | [976](/filings/0000950170-24-092813.md) | [1,014](/filings/0000950170-24-118247.md) | [1,021](/filings/0000950170-25-014483.md) | [1,086](/filings/0001193125-26-239333.md) | [1,115](/filings/0000950170-25-104056.md) | [1,112](/filings/0001193125-25-266982.md) | [1,117](/filings/0001193125-26-037613.md) | [1,128](/filings/0001193125-26-335147.md) | [1,290](/filings/0001193125-26-335147.md) |
| Total assets | $m | [1,669](/filings/0000950170-23-057501.md) | [1,869](/filings/0000950170-24-011727.md) | [1,923](/filings/0001193125-26-239333.md) | [1,987](/filings/0000950170-25-104056.md) | [2,028](/filings/0001193125-25-266982.md) | [2,037](/filings/0001193125-26-037613.md) | [2,110](/filings/0001193125-26-239333.md) | [2,149](/filings/0001193125-26-335147.md) | [2,121](/filings/0001193125-25-266982.md) | [2,114](/filings/0001193125-26-037613.md) | [2,132](/filings/0001193125-26-335147.md) | [2,148](/filings/0001193125-26-335147.md) |
| Current liabilities | $m | [243](/filings/0000950170-23-057501.md) | [339](/filings/0000950170-24-011727.md) | [390](/filings/0000950170-25-077746.md) | [419](/filings/0000950170-24-092813.md) | [419](/filings/0000950170-24-118247.md) | [394](/filings/0000950170-25-014483.md) | [451](/filings/0001193125-26-239333.md) | [466](/filings/0000950170-25-104056.md) | [429](/filings/0001193125-25-266982.md) | [412](/filings/0001193125-26-037613.md) | [455](/filings/0001193125-26-335147.md) | [471](/filings/0001193125-26-335147.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | [12.4](/filings/0000950170-23-057501.md) | [24.7](/filings/0000950170-24-011727.md) | [24.7](/filings/0000950170-25-077746.md) | [24.7](/filings/0000950170-24-092813.md) | [24.7](/filings/0000950170-24-118247.md) | [24.7](/filings/0000950170-25-014483.md) | [24.8](/filings/0001193125-26-239333.md) | [24.1](/filings/0000950170-25-104056.md) | [24.0](/filings/0001193125-25-266982.md) | [23.8](/filings/0001193125-26-037613.md) | [14.4](/filings/0001193125-26-335147.md) | [14.4](/filings/0001193125-26-335147.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-239333.md) | not reported | not reported | not reported | [9.3](/filings/0001193125-26-335147.md) | [9.3](/filings/0001193125-26-335147.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,340](/filings/0000950170-24-011727.md) | [1,422](/filings/0000950170-24-011727.md) | [1,422](/filings/0000950170-25-077746.md) | [1,451](/filings/0000950170-24-092813.md) | [1,492](/filings/0000950170-24-118247.md) | [1,528](/filings/0000950170-25-014483.md) | [1,544](/filings/0001193125-26-239333.md) | [1,570](/filings/0000950170-25-104056.md) | [1,581](/filings/0001193125-25-266982.md) | [1,592](/filings/0001193125-26-037613.md) | [1,573](/filings/0001193125-26-335147.md) | [1,573](/filings/0001193125-26-335147.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [54.3 d](/filings/0000950170-24-118247.md) | [89.5 d](/filings/0000950170-25-014483.md) | [4.1 d](/filings/0001193125-26-239333.md) | [84.6](/filings/0000950170-25-104056.md) | [59.8 d](/filings/0001193125-25-266982.md) | [50.4 d](/filings/0001193125-26-037613.md) | [46.0 d](/filings/0001193125-26-239333.md) | [75.3](/filings/0001193125-26-335147.md) | [75.9 d](/filings/0001193125-25-266982.md) | [100.0 d](/filings/0001193125-26-037613.md) | [52.7 d](/filings/0001193125-26-239333.md) | [72.5](/filings/0001193125-26-335147.md) |
| Capital expenditure | $m | [12.5 d](/filings/0000950170-24-118247.md) | [18.1 d](/filings/0000950170-25-014483.md) | [11.9 d](/filings/0001193125-26-239333.md) | [10.7](/filings/0000950170-25-104056.md) | [14.1 d](/filings/0001193125-25-266982.md) | [13.1 d](/filings/0001193125-26-037613.md) | [12.6 d](/filings/0001193125-26-239333.md) | [8.9](/filings/0001193125-26-335147.md) | [8.9 d](/filings/0001193125-25-266982.md) | [7.1 d](/filings/0001193125-26-037613.md) | [9.2 d](/filings/0001193125-26-239333.md) | [9.8](/filings/0001193125-26-335147.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-118247.md) | [0.0 d](/filings/0000950170-25-014483.md) | [0.0 d](/filings/0001193125-26-239333.md) | [20.0](/filings/0000950170-25-104056.md) | [20.0 d](/filings/0001193125-25-266982.md) | [20.0 d](/filings/0001193125-26-037613.md) | [20.0 d](/filings/0001193125-26-239333.md) | [50.0](/filings/0001193125-26-335147.md) | [50.0 d](/filings/0001193125-25-266982.md) | [50.0 d](/filings/0001193125-26-037613.md) | [50.0 d](/filings/0001193125-26-239333.md) | [50.0](/filings/0001193125-26-335147.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-10-01) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-07-01) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q1 FY2027 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.4](/filings/0000950170-23-057501.md) | [57.4](/filings/0000950170-24-011727.md) | [57.7](/filings/0000950170-24-092813.md) | [57.7](/filings/0000950170-24-118247.md) | [58.1](/filings/0000950170-25-014483.md) | [58.3](/filings/0000950170-25-104056.md) | [58.2](/filings/0001193125-25-266982.md) | [58.0](/filings/0001193125-26-037613.md) | [57.4](/filings/0001193125-26-335147.md) | [56.7](/filings/0001193125-25-266982.md) | [56.3](/filings/0001193125-26-037613.md) | [55.2](/filings/0001193125-26-335147.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 54,280,134 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335147.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.